4Front Ventures Corp. (FFNTF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
4Front Ventures Corp. (FFNTF) trades at $0.00 with AI Score 44/100 (Grade C). 4Front Ventures Corp. operates in the cannabis industry, focusing on the production, cultivation, and distribution of cannabis and CBD products. Market cap: $12,460, Sector: Healthcare.
Price live · AI analysis from Mar 17, 2026Analyst Coverage for FFNTF: FFNTF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates FFNTF against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
FFNTF: the 1 perspectives are evenly split.
How is this calculated? →4Front Ventures Corp. (FFNTF) Healthcare & Pipeline Overview
4Front Ventures Corp. cultivates, produces, and distributes cannabis and CBD products, operating licensed facilities and dispensaries primarily under the MISSION brand. With a focus on THC Cannabis and CBD Wellness, the company aims to expand its presence in state-licensed markets across the United States, facing competition in a rapidly evolving industry.
What Is the Investment Thesis for FFNTF?
Investing in 4Front Ventures Corp. involves several key considerations. The company's focus on both THC Cannabis and CBD Wellness provides diversification within the cannabis market. Growth catalysts include expansion into new state-licensed markets and increasing operational efficiency in existing facilities. The company's retail presence under the MISSION brand offers direct access to consumers. However, potential risks include regulatory changes in the cannabis industry and intense competition from other cannabis producers and retailers. With a negative P/E ratio and a negative profit margin of -94.1%, the company's financial performance requires close monitoring. The company's gross margin stands at 47.1%.
Based on FMP financials and quantitative analysis
FFNTF Key Highlights
- Operates six dispensaries in Massachusetts, Illinois, and Michigan as of December 31, 2021, primarily under the MISSION brand.
- Focuses on two segments: THC Cannabis and Cannabidiol (CBD) Wellness, providing diversification in the cannabis market.
- Sells equipment, supplies, and intellectual property to other cannabis producers, adding a revenue stream beyond direct cannabis sales.
- Gross Margin of 47.1% indicates potential for profitability improvements through operational efficiencies.
- Beta of 0.22 suggests lower volatility compared to the overall market, which may appeal to risk-averse investors.
Who Are FFNTF's Competitors?
FFNTF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| ALIM Alimera Sciences, Inc. | $5.54 | -0.18% | $301.29M | 60 |
| EGRX Eagle Pharmaceuticals, Inc. | $0.67 | +0.00% | $8.82M | 60 |
| ADMP Adamis Pharmaceuticals Corporation | $0.78 | +0.85% | $7.25M | 61 |
| DCPH Deciphera Pharmaceuticals | $25.59 | +0.08% | $2.21B | 61 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are FFNTF's Key Strengths?
- Licensed facilities in multiple states.
- Vertically integrated operations.
- Established brand presence.
- Diversified product offerings.
What Are FFNTF's Weaknesses?
- Negative profit margin.
- Limited geographic reach.
- Dependence on regulatory approvals.
- High operating expenses.
What Could Drive FFNTF Stock Higher?
- Potential regulatory changes in key states could expand market access.
- Increasing consumer demand for cannabis and CBD products.
- Expansion of the MISSION brand dispensaries.
- Development of new and innovative cannabis products.
What Are the Key Risks for FFNTF?
- Financial-distress signal — its Altman Z-Score of -2.71 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Regulatory changes could negatively impact operations.
- Intense competition from other cannabis companies.
- Price volatility in the cannabis market.
- Dependence on regulatory approvals for expansion.
- Negative profit margin and financial performance.
What Are the Growth Opportunities for FFNTF?
- Expansion into New State-Licensed Markets: 4Front Ventures can expand its operations into new states as they legalize cannabis for medical or recreational use. This expansion would increase the company's market reach and revenue potential. The timeline for this growth depends on the pace of legalization in different states. The market size for newly legalized states can be substantial, potentially adding millions of dollars in revenue. A competitive advantage would be securing licenses early and establishing a strong presence before competitors.
- Increasing Operational Efficiency: Improving operational efficiency in existing facilities can significantly reduce costs and increase profitability. This includes optimizing cultivation techniques, streamlining production processes, and improving supply chain management. The timeline for these improvements is ongoing, with continuous efforts to enhance efficiency. The market size for cost savings can be substantial, potentially improving profit margins by several percentage points. A competitive advantage would be implementing innovative technologies and best practices to achieve superior efficiency.
- Product Innovation and Development: Developing new and innovative cannabis and CBD products can attract new customers and increase sales. This includes creating unique formulations, delivery methods, and product formats. The timeline for product development is ongoing, with continuous efforts to innovate and meet changing consumer preferences. The market size for new products can be substantial, potentially adding millions of dollars in revenue. A competitive advantage would be developing products that are differentiated and meet specific consumer needs.
- Strategic Partnerships and Acquisitions: Forming strategic partnerships or acquiring other cannabis companies can expand 4Front Ventures' market reach and product offerings. This includes partnering with other producers, retailers, or technology providers. The timeline for partnerships and acquisitions is opportunistic, depending on available opportunities. The market size for expanded reach and offerings can be substantial, potentially adding millions of dollars in revenue. A competitive advantage would be identifying and securing partnerships or acquisitions that are strategically aligned with 4Front's goals.
- Strengthening Brand Recognition: Building a strong brand reputation can increase customer loyalty and attract new customers. This includes investing in marketing and advertising, providing excellent customer service, and ensuring product quality. The timeline for brand building is ongoing, with continuous efforts to enhance brand recognition. The market size for increased loyalty and attraction can be substantial, potentially adding millions of dollars in revenue. A competitive advantage would be creating a brand that is trusted and respected by consumers.
What Opportunities Does FFNTF Have?
- Expansion into new markets.
- Increasing recreational cannabis legalization.
- Product innovation and development.
- Strategic partnerships and acquisitions.
What Threats Does FFNTF Face?
- Regulatory changes.
- Intense competition.
- Price volatility.
- Economic downturn.
What Are FFNTF's Competitive Advantages?
- Licensed facilities in state-licensed markets.
- Established retail presence under the MISSION brand.
- Diversified revenue streams through cultivation, production, and retail.
- Expertise in cannabis cultivation and production.
What Does FFNTF Do?
4Front Ventures Corp., founded in 2011 and headquartered in Phoenix, Arizona, is a cannabis company focused on the production, cultivation, and distribution of cannabis and CBD products in the United States. The company operates through two segments: THC Cannabis and Cannabidiol (CBD) Wellness. 4Front manages licensed cannabis facilities in state-licensed markets, producing and distributing cannabis and CBD products. As of December 31, 2021, 4Front operated six dispensaries in Massachusetts, Illinois, and Michigan, primarily under the MISSION brand name. In addition to its retail operations, 4Front Ventures sells equipment, supplies, and intellectual property to cannabis producers. The company also imports and sells equipment and supplies, leases real estate properties to cannabis producers, and offers consulting services. 4Front's business model integrates cultivation, processing, and retail, aiming to provide a comprehensive suite of products and services within the cannabis industry. The company aims to expand its footprint and product offerings in key markets, focusing on operational efficiency and product quality.
What Products and Services Does FFNTF Offer?
- Cultivates cannabis plants in licensed facilities.
- Produces a variety of cannabis and CBD products.
- Distributes cannabis and CBD products to dispensaries.
- Operates dispensaries under the MISSION brand.
- Sells equipment and supplies to other cannabis producers.
- Leases real estate properties to cannabis producers.
- Offers consulting services to cannabis businesses.
How Does FFNTF Make Money?
- Cultivation and production of cannabis and CBD products.
- Retail sales through company-owned dispensaries.
- Wholesale distribution to other dispensaries.
- Ancillary services such as equipment sales and consulting.
What Industry Does FFNTF Operate In?
4Front Ventures Corp. operates in the rapidly growing cannabis industry, which is characterized by increasing legalization and acceptance of cannabis and CBD products. The market includes both medical and recreational cannabis, with varying regulations across different states. The industry is highly competitive, with numerous companies vying for market share. 4Front competes with other cannabis producers, retailers, and suppliers. The company's success depends on its ability to navigate regulatory complexities, establish brand recognition, and achieve operational efficiency. The industry is expected to continue growing as more states legalize cannabis and consumer demand increases.
Who Are FFNTF's Key Customers?
- Recreational cannabis consumers.
- Medical cannabis patients.
- Other cannabis producers.
- Cannabis dispensaries.
How 4Front Ventures Corp. Is Valued
4Front Ventures Corp. carries a market capitalization of 12K, placing it in the micro-cap category. Relative to its peer group, FFNTF's quantitative score of 44/100 is below the peer average of 66/100.
Key Financial Metrics
Return on assets is -34.7%, showing how much profit it generates from its asset base. A current ratio of 0.33 means current liabilities exceed short-term assets, a liquidity point worth watching.
F-Score 3/9Financial Health
4Front Ventures Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -2.71 places it in the distress zone, a signal of elevated financial risk.
FY2026 estForward Outlook
Wall Street analysts project 4Front Ventures Corp. revenue of about $363.5M for fiscal 2026, with EPS near $0.20.
FFNTF Financials
Bull Case vs Bear Case
Bull Case
- Licensed facilities in multiple states.
- Vertically integrated operations.
- Established brand presence.
- Diversified product offerings.
Bear Case
- Negative profit margin.
- Limited geographic reach.
- Dependence on regulatory approvals.
- High operating expenses.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
FFNTF Latest News
No recent news available for FFNTF.
FFNTF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for FFNTF.
Price Targets
Wall Street price target analysis for FFNTF.
FFNTF MoonshotScore
What does this score mean?
The MoonshotScore rates FFNTF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Andrew Fisher Thut
CEO
Andrew Fisher Thut serves as the CEO of 4Front Ventures Corp. His background includes experience in managing and operating businesses in the cannabis industry. He is responsible for overseeing the company's strategic direction, operational performance, and financial results. His leadership is focused on expanding 4Front's market presence and enhancing its product offerings. He manages a workforce of 374 employees.
Track Record: Under Andrew Fisher Thut's leadership, 4Front Ventures has focused on expanding its operations in key state-licensed markets and improving its operational efficiency. Key milestones include the expansion of the MISSION brand dispensaries and the development of new cannabis and CBD products. The company has also focused on strategic partnerships and acquisitions to enhance its market position.
FFNTF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that 4Front Ventures Corp. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited information available to investors, increasing the risk associated with investing in these securities. Trading on the OTC Other tier often involves greater price volatility and lower liquidity compared to stocks listed on major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases investment risk.
- Lower liquidity can lead to price volatility.
- OTC stocks are more susceptible to fraud and manipulation.
- Regulatory oversight is less stringent compared to major exchanges.
- The 'Unknown' disclosure status adds uncertainty.
- Verify the company's legal standing and registration.
- Review available financial statements and disclosures.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Monitor news and regulatory filings for any red flags.
- Understand the risks associated with OTC trading.
- Consult with a financial advisor before investing.
- Operation of dispensaries under the MISSION brand.
- Presence in multiple state-licensed markets.
- Focus on both THC Cannabis and CBD Wellness.
- Management team with industry experience.
- Company founded in 2011 suggests some operating history.
Common Questions About FFNTF (Healthcare)
What does 4Front Ventures Corp. do?
4Front Ventures Corp. is a cannabis company that cultivates, produces, and distributes cannabis and CBD products. The company operates licensed facilities and dispensaries in state-licensed markets across the United States. Its business model includes cultivation, processing, retail sales through company-owned dispensaries under the MISSION brand, and wholesale distribution to other dispensaries. Additionally, 4Front Ventures sells equipment and supplies to other cannabis producers and offers consulting services. The company focuses on both THC Cannabis and CBD Wellness segments, aiming to provide a comprehensive suite of products and services within the cannabis industry.
What are the main risks for FFNTF?
The main risks for 4Front Ventures Corp. include regulatory changes in the cannabis industry, which could impact the company's ability to operate and expand. Intense competition from other cannabis companies poses a threat to market share and profitability. Price volatility in the cannabis market can affect revenue and earnings. The company's dependence on regulatory approvals for expansion creates uncertainty. Additionally, 4Front Ventures' negative profit margin and financial performance raise concerns about its long-term sustainability. Investors should carefully consider these risks before investing in FFNTF.
What are the key factors to evaluate for FFNTF?
4Front Ventures Corp. (FFNTF) holds an AI score of 44/100 (low). Not financial advice.
How frequently does FFNTF data refresh on this page?
FFNTF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven FFNTF's recent stock price performance?
4Front Ventures Corp. (FFNTF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Licensed facilities in multiple states. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider FFNTF overvalued or undervalued right now?
Valuing 4Front Ventures Corp. (FFNTF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying FFNTF?
Before investing in 4Front Ventures Corp. (FFNTF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding FFNTF to a portfolio?
Key strength of 4Front Ventures Corp. (FFNTF): Licensed facilities in multiple states. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Financial data is based on the most recent available information.
- OTC market data may be limited and less reliable than data from major exchanges.